Company / Revenue per Share
NeoGenomics Laboratories, Inc. Revenue per Share History
FY2016-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.78
FY2017
5-year range
-
FY2016-FY2017
Trend
-75.6%
vs FY2016
Sector context
#148 of 153
Health Care
What the data says
Among 153 Health Care companies, NeoGenomics Laboratories, Inc. is in the bottom 3% for revenue per share.
Based on SEC 10-K filings.
0.78 in FY2017.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 153This company $0.78 Sector average $123.62
▼
-99.4% below sector average
Key checks
Key Insights
- In FY2017, revenue per share decreased 75.6% year-over-year.
- Ranks #148 out of 153 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | $0.78 | -75.6% |
| FY2016 | $3.22 | +3778.7% |
As of FY2017 · SEC 10-K · Updated Jun 30, 2026